FDA Warns Electronic Cigarettes Pose Public Health Risk
This article was originally published in The Tan Sheet
Executive Summary
FDA has not determined its enforcement approach for electronic cigarettes, but says products it examined contained toxic chemicals
You may also be interested in...
Advisory Committee On NRT Indications Appears Likely Following Workshop
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.
Federal court lifts import ban on e-cigarettes
The U.S. District Court for the District of Columbia grants electronic cigarette distributors a preliminary injunction that allows them to be classified as tobacco products. The decision overturns FDA's interpretation that the products were unapproved drug devices and agrees with arguments made by law firm Latham & Watkins on behalf of Sottera, a distributor of e-cigarette brand Njoy, according to a Jan. 14 release. FDA in July warned consumers about the e-cigarettes and stopped shipments from entering the U.S. because tested lots contained toxic materials (1"The Tan Sheet" July 27, 2009)
Nicotine Replacement Therapy Potential Smolders Around Electronic Cigarettes
Manufacturers say e-cigarettes have potential for smoking cessation, but should not have to get regulatory approval,; critics say the devices should be subject to FDA review.